Investing.com - Oramed announced third quarter earnings that beat analysts' expectations on Wednesday and revenue that fell short of forecasts.
The company reported earnings per share of $-0.08 on revenue of $666.0K. Analysts polled by Investing.com anticipated EPS of $-0.25 on revenue of $733.33K. .
Oramed share's are down 62% since the start of the year , still down 67.52% from its 52 week high of $13.73 set on Thursday, January 5, 2023.
Oramed follows other major Healthcare sector earnings this month
On Thursday, April 27, 2023, Eli Lilly reported first quarter EPS of $1.62 on revenue of $6.96B, compared with a forecasts for EPS of $1.69 on revenue of $6.84B.
Novo Nordisk ADR earnings beat analysts' expectations on Thursday, May 4, 2023, with first quarter EPS of $1.3 on revenue of $7.88B. Investing.com analysts anticipated EPS of $1.24 on revenue of $7.66B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar